Feasibility and acceptance of simultaneous amyloid PET/MRI

Purpose Established Alzheimer’s disease (AD) biomarker concepts classify into amyloid pathology and neuronal injury biomarkers, while recent alternative concepts classify into diagnostic and progression AD biomarkers. However, combined amyloid positron emission tomography/magnetic resonance imaging...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of nuclear medicine and molecular imaging 2016-11, Vol.43 (12), p.2236-2243
Hauptverfasser:	Schütz, Lisa, Lobsien, Donald, Fritzsch, Dominik, Tiepolt, Solveig, Werner, Peter, Schroeter, Matthias L., Berrouschot, Jörg, Saur, Dorothee, Hesse, Swen, Jochimsen, Thies, Rullmann, Michael, Sattler, Bernhard, Patt, Marianne, Gertz, Hermann-Josef, Villringer, Arno, Claßen, Joseph, Hoffmann, Karl-Titus, Sabri, Osama, Barthel, Henryk
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Alzheimer Disease - diagnostic imaging Alzheimer Disease - metabolism Alzheimer's disease Amyloid - metabolism Attitude of Health Personnel Biomarkers - metabolism Cardiology Cognitive Dysfunction - diagnostic imaging Cognitive Dysfunction - metabolism Feasibility Studies Female Humans Image Enhancement - methods Imaging Magnetic Resonance Imaging - methods Male Medical imaging Medicine Medicine & Public Health Molecular Imaging - methods Multimodal Imaging - methods Nuclear Medicine Oncology Original Article Orthopedics Pathology Patient Acceptance of Health Care Positron-Emission Tomography - methods Radiology Reproducibility of Results Sensitivity and Specificity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!